A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease
2013 ◽
Vol 29
(S1)
◽
pp. 7-20
◽
Masahiro Jinzaki
◽
Masaharu Hirano
◽
Kazuhiro Hara
◽
Takahiko Suzuki
◽
Akira Yamashina
◽
...
2017 ◽
Vol Volume 10
◽
pp. 867-880
◽
Ikuko Yataba
◽
Noboru Otsuka
◽
Isao Matsushita
◽
Hideo Matsumoto
◽
Yuichi Hoshino
2008 ◽
Vol 15
(9)
◽
pp. 809-815
◽
Yukio Homma
◽
Takuhiro Yamaguchi
◽
Osamu Yamaguchi
2001 ◽
Vol 11
◽
pp. S301-S302
◽
2012 ◽
Vol 18
(2)
◽
pp. 133-144
◽
Valerie K. Arnold
◽
David Feifel
◽
Craig Q. Earl
◽
Ronghua Yang
◽
Lenard A. Adler
2018 ◽
Vol 30
(12)
◽
pp. e13442
◽
Shin Fukudo
◽
Hiroto Miwa
◽
Atsushi Nakajima
◽
Yoshikazu Kinoshita
◽
Masanori Kosako
◽
...
Randa Salet
◽
Michelle Rosenzwajg
◽
Roberta Lorenzon
◽
Alexandra Roux
◽
Jean Claude Carel
◽
...
2014 ◽
Vol 7
(2)
◽
pp. 84-92
◽
Osamu YAMAGUCHI
◽
Eiji MARUI
◽
Yasuhiko IGAWA
◽
Masayuki TAKEDA
◽
Osamu NISHIZAWA
◽
...
1996 ◽
Vol 6
(S1)
◽
pp. 301-301
◽
P. Ravn
◽
B. Clemmesen
◽
B. J. Riis
◽
C. Christiansen
2018 ◽
Vol 13
(10)
◽
pp. e0204896
◽
Tadao Akizawa
◽
Ryutaro Shimazaki
◽
Masafumi Fukagawa
◽
1996 ◽
Vol 10
(1)
◽
pp. 59-66
◽
Julian Rosenthal
◽
Norbert Hittel
◽
Karl Otto Stumpe
Close
Export Citation Format
Close
Share Document
Close